Senile plaques in temporal lobe epilepsy

[1]  Alistair Burns,et al.  Observations on the brains of demented old people. B.E. Tomlinson, G. Blessed and M. Roth, Journal of the Neurological Sciences (1970) 11, 205–242; (1968) 7, 331–356 , 1997 .

[2]  S. Younkin,et al.  Release of excess amyloid beta protein from a mutant amyloid beta protein precursor. , 1993, Science.

[3]  J. Kimura,et al.  Regional accumulation of amyloid β A4 protein precursor in the gerbil brain following transient cerebral ischemia , 1992, Neuroscience Letters.

[4]  Bradley T. Hyman,et al.  Distribution of Alzheimer‐type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease , 1992, Neurology.

[5]  P. Lantos,et al.  βA4 deposition in the temporal cortex of adults with Down's syndrome , 1992, Journal of the Neurological Sciences.

[6]  L. Amaducci,et al.  Risk Factors for Alzheimer’s Disease , 2020, Science Insights.

[7]  D. Selkoe,et al.  The Seminal Role of β‐Amyloid in the Pathogenesis of Alzheimer Disease , 1992 .

[8]  D. Selkoe,et al.  Identification of a stable fragment of the Alzheimer amyloid precursor containing the beta-protein in brain microvessels. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[9]  S. Younkin,et al.  Potentially amyloidogenic, carboxyl-terminal derivatives of the amyloid protein precursor. , 1992, Science.

[10]  M. Mattson,et al.  beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity , 1992, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[11]  P. Greengard,et al.  Alzheimer beta/A4 amyloid precursor protein in human brain: aging-associated increases in holoprotein and in a proteolytic fragment. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[12]  D J Ballard,et al.  Clinical risk factors for Alzheimer's disease , 1991, Neurology.

[13]  M. Beal,et al.  An in vivo model for the neurodegenerative effects of beta amyloid and protection by substance P. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[14]  J. Miller,et al.  Effect of pre- and postmortem variables on specific mRNA levels in human brain. , 1991, Brain research. Molecular brain research.

[15]  J. Price,et al.  The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease , 1991, Neurobiology of Aging.

[16]  R. Tanzi,et al.  Selective induction of Kunitz-type protease inhibitor domain-containing amyloid precursor protein mRNA after persistent focal ischemia in rat cerebral cortex , 1991, Neuroscience Letters.

[17]  R. Tanzi,et al.  Induction of amyloid precursor protein mRNA after heat shock in cultured human lymphoblastoid cells , 1991, Neuroscience Letters.

[18]  S. Tsuji,et al.  Mis-sense mutation Val→Ile in exon 17 of amyloid precursor protein gene in Japanese familial Alzheimer's disease , 1991, The Lancet.

[19]  J. Hardy,et al.  Amyloid precursor protein gene mutation in early-onset Alzheimer's disease , 1991, The Lancet.

[20]  D. Selkoe.  The molecular pathology of Alzheimer's disease , 1991, Neuron.

[21]  M. Pericak-Vance,et al.  Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease , 1991, Nature.

[22]  T. Koepsell,et al.  A case‐control study of Alzheimer's disease , 1990, Annals of neurology.

[23]  C. Cotman,et al.  β-Amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage , 1990, Brain Research.

[24]  D. Sparks,et al.  Cortical senile plaques in coronary artery disease, aging and Alzheimer's disease , 1990, Neurobiology of Aging.

[25]  Anthony F Jorm,et al.  A case‐control study of Alzheimer's disease in Australia , 1990, Neurology.

[26]  D. Kirschner,et al.  Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. , 1990, Science.

[27]  J. Garthwaite,et al.  Excitatory amino acid neurotoxicity and neurodegenerative disease. , 1990, Trends in pharmacological sciences.

[28]  C. Duyckaerts,et al.  Large amounts of neocortical βA4 deposits without neuritic plaques nor tangles in a psychometrically assessed, non-demented person , 1990, Neuroscience Letters.

[29]  T. Oltersdorf,et al.  Cleavage of amyloid beta peptide during constitutive processing of its precursor. , 1990, Science.

[30]  D. Price,et al.  Evidence that beta-amyloid protein in Alzheimer's disease is not derived by normal processing. , 1990, Science.

[31]  S. Younkin,et al.  Expression of β amyloid protein precursor mRNAs: Recognition of a novel alternatively spliced form and quantitation in alzheimer's disease using PCR , 1990, Neuron.

[32]  A. Hofman,et al.  History of dementia and Parkinson's disease in 1st‐degree relatives of patients with Alzheimer's disease , 1989, Neurology.

[33]  G. Heinrich.  Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease. , 1989, The New England journal of medicine.

[34]  A. Young,et al.  Excitatory amino acids and Alzheimer's disease , 1989, Neurobiology of Aging.

[35]  E. Schon,et al.  Widespread expression of amyloid beta-protein precursor gene in rat brain. , 1989, The American journal of pathology.

[36]  D. Mann,et al.  The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome , 1989, Journal of the Neurological Sciences.

[37]  R. Martins,et al.  A4 amyloid protein deposition and the diagnosis of Alzheimer's disease , 1988, Neurology.

[38]  L. G. Davis,et al.  Immunocytochemical localization of the precursor protein for β-amyloid in the rat central nervous system , 1988, Neuron.

[39]  D. Choi,et al.  Glutamate neurotoxicity and diseases of the nervous system , 1988, Neuron.

[40]  David M. A. Mann,et al.  The pathological association between down syndrome and Alzheimer disease , 1988, Mechanisms of Ageing and Development.

[41]  G. Multhaup,et al.  Alzheimer's disease amyloidogenic glycoprotein: expression pattern in rat brain suggests a role in cell contact. , 1988, The EMBO journal.

[42]  S. Shiojiri,et al.  Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity , 1988, Nature.

[43]  C. Masters,et al.  Localization of the putative precursor of Alzheimer's disease‐specific amyloid at nuclear envelopes of adult human muscle. , 1988, The EMBO journal.

[44]  M. Goedert.  Neuronal localization of amyloid beta protein precursor mRNA in normal human brain and in Alzheimer's disease. , 1987, The EMBO journal.

[45]  H. Wiśniewski,et al.  Molecular cloning and characterization of a cDNA encoding the cerebrovascular and the neuritic plaque amyloid peptides. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[46]  P. Yates,et al.  THE TOPOGRAPHIC DISTRIBUTION OF SENILE PLAQUES AND NEUROFIBRILLARY TANGLES IN THE BRAINS OF NON‐DEMENTED PERSONS OF DIFFERENT AGES , 1987, Neuropathology and applied neurobiology.

[47]  M. Lerman,et al.  Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. , 1987, Science.

[48]  P. S. St George-Hyslop,et al.  Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. , 1987, Science.

[49]  C Oliver,et al.  Down's Syndrome and Alzheimer's disease: a review , 1986, Psychological Medicine.

[50]  C. Masters,et al.  Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[51]  J. Ulrich,et al.  Alzheimer changes in nondemented patients younger than sixty‐five: Possible early stages of Alzheimer's disease and senile dementia of Alzheimer type , 1985, Annals of neurology.

[52]  Y. Ben-Ari,et al.  Limbic seizure and brain damage produced by kainic acid: Mechanisms and relevance to human temporal lobe epilepsy , 1985, Neuroscience.

[53]  G. Glenner,et al.  Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein , 1984 .

[54]  L. Whalley,et al.  The Dementia of Down's Syndrome and its Relevance to Aetiological Studies of Alzheimer's Disease , 1982, Annals of the New York Academy of Sciences.

[55]  J H Margerison,et al.  Epilepsy and the temporal lobes. A clinical, electroencephalographic and neuropathological study of the brain in epilepsy, with particular reference to the temporal lobes. , 1966, Brain : a journal of neurology.

[56]  S. Hirai,et al.  Diffuse type of senile plaques in the brains of Alzheimer-type dementia , 1988, Acta Neuropathologica.

[57]  S. Hirai,et al.  Distinctive, rapid, and easy labeling of diffuse plaques in the Alzheimer brains by a new methenamine silver stain , 2004, Acta Neuropathologica.

[58]  R. S. Williams,et al.  Age-related changes in the density and morphology of plaques and neurofibrillary tangles in Down syndrome brain , 2004, Acta Neuropathologica.

[59]  D. Neary,et al.  Deposition of amyloid β protein in non-Alzheimer dementias: evidence for a neuronal origin of parenchymal deposits of β protein in neurodegenerative disease , 2004, Acta Neuropathologica.

[60]  A Hofman,et al.  Risk Factors for Alzheimer's Disease: Overview of the EURODEM Collaborative Re-Analysis of Case-Control Studies , 1991 .

[61]  F. Mastaglia,et al.  AMYLOID (A4) PROTEIN DEPOSITION IN BRAIN IN PROGRESSIVE SUPRANUCLEAR PALSY (PSP) , 1988 .

[62]  R. Tanzi,et al.  Amyloid β protein gene: cDNA, mRNA distribution and genetic linkage near the Alzheimer locus , 1988 .

[63]  F. Mastaglia,et al.  DEPOSITION OF AMYLOID (A4) PROTEIN IN THE CEREBRAL CORTEX IN PARKINSON'S DISEASE (PD) , 1988 .

[64]  B. Seltzer,et al.  Risk factors for Alzheimerʼs disease: a case-control study , 1988 .

[65]  B. Frangione.  FAMILIAL AND SPORADIC CEREBRAL AMYLOID ANGIOPATHY , 1988 .

[66]  K. Grzeschik,et al.  The precursor of Alzheimer??s disease amyloid A4 protein resembles a cell-surface receptor , 1987 .

[67]  G. Glenner,et al.  Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. , 1984, Biochemical and biophysical research communications.

[68]  Corsellis Ja,et al.  Neuropathology of status epilepticus in humans. , 1983, Advances in neurology.

[69]  J. Corsellis.  The neuropathology of temporal lobe epilepsy. , 1970, Modern trends in neurology.

[70]  Corsellis Ja.  The neuropathology of temporal lobe epilepsy. , 1970 .

[71]  M. Roth,et al.  Observations on the brains of non-demented old people. , 1968, Journal of the neurological sciences.